The Role of Immunological and Clinical Biomarkers to Predict Clinical COVID-19 Severity and Response to Therapy—A Prospective Longitudinal Study

BACKGROUND: The association of pro-inflammatory markers such as interleukin-6 (IL-6) and other biomarkers with severe coronavirus disease 2019 (COVID-19) is of increasing interest, however their kinetics, response to current COVID-related treatments, association with disease severity and comparison...

Descripción completa

Detalles Bibliográficos
Autores principales: Copaescu, Ana, James, Fiona, Mouhtouris, Effie, Vogrin, Sara, Smibert, Olivia C., Gordon, Claire L., Drewett, George, Holmes, Natasha E., Trubiano, Jason A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009986/
https://www.ncbi.nlm.nih.gov/pubmed/33815405
http://dx.doi.org/10.3389/fimmu.2021.646095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8009986/
https://www.ncbi.nlm.nih.gov/pubmed/33815405
http://dx.doi.org/10.3389/fimmu.2021.646095

Ejemplares similares